December 8, 2020
Mayo study explores benefits of genetic testing for healthy people
More than 1 in 10 people who had predictive genomic testing ― testing that looks for genetic mutations in otherwise healthy people ― learned that they had a hereditary risk for a health condition and may benefit from preventive care, according to a recent study published in Mayo Clinic Proceedings. This study is the first […]
Tags: #predictive genomics, Genetic Testing, Jennifer L. Anderson, mayo clinic, Mayo Clinic Center for Individualized Medicine, Mayo Clinic Proceedings
December 2, 2019
Precision genomics may offer clues to unexplained low blood cell counts
By Jay Furst
Precision genomics has opened the door to identifying the drivers for cancer and other diseases. Its value as a diagnostic tool isn’t limited to the underlying disease biology, however. It also can help diagnose and determine targeted therapies for patients with unexplained illnesses. Mrinal Patnaik, M.B.B.S., a Mayo Clinic hematologist, and colleagues conducted research with […]
Tags: #Mrinal Patnaik, #undiagnosed diseases, center for individualized medicine, cytopenia, genomics, inherited bone marrow failure syndrome, low blood cell count, mayo clinic, Mayo Clinic Proceedings, stem cell transplant
June 3, 2019
Identifying hereditary cancer risk: genetic testing can lead to better screening, earlier treatment
By Sharon Rosen
Do you have family members who have been diagnosed with gastrointestinal, breast or ovarian cancer? According to a recent Mayo Clinic study, nearly 5% to 10% of these cancers can be hereditary. That’s why it is important to share your family medical history with your physician, who can determine if you and your family members […]
Tags: #cancer risk, #Center for Individualized Mediicine, #gastrointestinal cancer, breast cancer, colorectal cancer, Dr. Niloy "Jewel" Samadder, Genetic Testing, genomics, hereditary cancer, lynch syndrome, mayo clinic, Mayo Clinic Proceedings
January 29, 2018
Direct-to-consumer genetic testing–a rapidly shifting landscape
Direct-to-consumer genetic or over the counter testing emerged in the early 2000s as a means of allowing consumers to access information about their genetics without the involvement of a physician. While early models were popular with consumers, they were controversial in medical and regulatory circles. In the January 2018 issue of Mayo Clinic Proceedings authors […]
Tags: #David Robinson, #DNA analysis, #Dr. Megan Allyse, #DTC genomic tests, #medical education, #Symposium on Precision Medicine, Bioethics, biomedical ethics, center for individualized medicine, Dr. Matthew Ferber, Dr. Richard Sharp, mayo clinic
December 7, 2017
Microbiome emerges at the frontier of precision medicine
Our genes help determine what makes us unique, such as our eye color, height and whether we are left- or right-handed. But did you know that you also have a unique community of bacteria that live in and on your body, known as your microbiome? Research has shown that a person’s microbiome affects their health […]
Tags: #CIMCon17, #Dr. Eran Elinav, #Dr. Eran Segal, #gut mircrobiome, #Individualized Medicine 2017, #individualized treatment, #personalized diet, #probiotics, #symbiotics, center for individualized medicine, Dr. Heidi Nelson, Dr. Nicholas Chia
November 28, 2017
From pharmacogenomics to pharmaco-omics – individualized care for every patient
By Sharon Rosen
When prescribing a medication for you, your physician considers many factors, including your age, sex, weight and current health conditions. Now, add to that list your unique genetic characteristics. Your genes affect the way you respond to medications. Pharmacogenomics is a term used to describe the use of genomic information to help select the right […]
Tags: #drug-gene interactions, #pharmacogenomics testing, #RIGHT 10K study, center for individualized medicine, Dr. Liewei Wang, Dr. Richard Weinshilboum, individualized medicine, mayo clinic, Mayo Clinic Proceedings, pharmacogenomics
November 7, 2017
Twenty-first century precision medicine cancer care
By Sharon Rosen
As genomic sequencing has become faster and less expensive, physicians have used this new technology to guide and manage care for patients with cancer. Genomic testing, also known as genomic profiling, was initially used for patients with advanced cancer when standard therapy failed. The goal of the testing was to identify unique genetic characteristics of […]
Tags: #cancer treatment, #Dr. Mitesh Borad, #genetic panel tests, #Genomic profiling, #targeted therapies, #tissue biopsy, #tumor sequencing, cancer, center for individualized medicine, Dr. Patricia LoRusso, mayo clinic, Mayo Clinic Proceedings
July 19, 2017
Genetic testing for earlier diagnosis and treatment of rheumatoid arthritis
By Sharon Rosen
If you are one of the estimated 1.5 million Americans who suffer from rheumatoid arthritis, you know about the painful, swollen and stiff joints that are common symptoms of this chronic inflammatory disorder. Mayo Clinic has been a leader in discovering biomarkers – indicators of health and disease – that link rheumatoid arthritis to the […]
Tags: #CIMCon17, #Dr. Carla Wijbrandts, #Dr. Paul-Peter Tak, #drug response, #drug safety, #Individualizing Medicine 2017, biomarkers, center for individualized medicine, Dr. Eric Matteson, individualized medicine, mayo clinic, Mayo Clinic Proceedings
June 16, 2017
Genetic testing helps guide diagnosis and treatment for digestive and liver diseases
By Sharon Rosen
Many disorders of the digestive tract and liver can cause chronic, debilitating symptoms that begin in infancy or early childhood and require treatment to prevent the disease from progressing. Mayo Clinic is the first medical center to integrate genomic testing into personalized care plans for patients with some digestive and liver diseases. Researchers have discovered […]
Tags: #Dr. Lisa Boardman, #Dr. Michael Stephens, #Gastroenterology and Hepatology Clinic, #gastrointestinal cancer, #gastrointestinal disorders, #gene panel testing, #Individualizing Medicine Clinic, #liver cancer, #medical resesarch, center for individualized medicine, Dr. Konstantinos Lazaridis, Genetic Testing
April 14, 2017
Precision care for heart disease – a practical approach
By Sharon Rosen
Heart disease can sometimes be a silent killer. Many of us know seemingly healthy people who’ve suddenly or unexpectedly had a heart attack. It can be shocking when people who are at a a healthy weight and exercise regularly die from heart disease that they never knew they had. Many forms of heart disease can […]
Tags: #atrial fibrillation, #cardiology, #Dr. Iftkhar Kullo, #Dr. John Giudicessi, #Dr. Michael Ackerman, #drug-gene reactions, #familial cardiovascular diseases, #sudden cardiac death, #targeted therapies, center for individualized medicine, coronary heart disease, Genetic Testing